Skip to content

Calcipotriene/betamethasone in the treatment of psoriasis: a review article

Calcipotriene/betamethasone in the treatment of psoriasis: a review article 1

Calcipotriene/betamethasone in the treatment of psoriasis: A review article on ResearchGate, the professional network for scientists. This article reviews the efficacy, safety, and patient acceptability of calcipotriol/betamethasone dipropionate. The combination of calcipotriene and betamethasone is more effective and better tolerated than either component alone.

Calcipotriene/betamethasone in the treatment of psoriasis: a review article 2Calcipotriol/betamethasone dipropionate is a fixed combination of the synthetic vitamin D3 analog calcipotriol (also known as calcipotriene) and the synthetic corticosteroid betamethasone dipropionate for the treatment of plaque psoriasis in adults. Calcipotriene/betamethasone in the treatment of psoriasis: a review article. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Figure 1: Topical therapy for management of psoriasis. This article provides a review of a patented topical suspension combination formulation of C/Bd-TS, including formulation characteristics, perspectives on modes of action, outcomes from pivotal trials, and efficacy and safety data reported from additional studies.

Review article. To optimize the topical treatment of psoriasis in Saudi Arabia, the Saudi Society of Dermatology and Dermatologic surgery (SSDDS) have initiated a project to develop guidelines for the management of psoriasis. Combination of calcipotriol/betamethasone dipropionate ointment. REVIEW ARTICLE Year: 2016 Volume: 82 Issue: 2 Page: 135-144 Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review Ru Yan, Shibin Jiang, Yan Wu, Xing-Hua Gao, Hong-Duo Chen Department of Dermatology, No. How to cite this article:Yan R, Jiang S, Wu Y, Gao XH, Chen HD. 5 mg/g) is a fixed-dose combination of a vitamin D(3) analogue and a corticosteroid indicated for the once-daily, topical treatment of psoriasis vulgaris of the trunk, limbs and scalp in adults.


Topical therapies remain the mainstay of psoriasis treatment; however, these are associated with additional challenges where preparations may be perceived as messy, inconvenient and time-consuming. Applicator device Betamethasone dipropionate Calcipotriene Calcipotriol Gel Psoriasis vulgaris Topical treatments Topical suspension. The online version of this article (doi:10. Adherence to medication in patients with psoriasis: a systematic literature review. Scalp psoriasis: a review of current topical treatments options. Calcipotriol solution for the treatment of scalp psoriasis: evaluation of efficacy, safety and acceptance in 3396 patients. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. PubMed journal article Treatment of psoriasis: role of calcipotrien was found in Unbound MEDLINE. Calcipotriene/betamethasone in the treatment of psoriasis: a review article. Two plaques of chronic stable plaque psoriasis in the same patient with identical EID score were selected randomly. S. Calcipotriene/betamethasone in the treatment of psoriasis: a review article. Most psoriasis patients are treated with topicals. The goal of this activity is to review the latest research on the topical treatment of psoriasis. A systematic review of CM for psoriasis treatment, including 32 randomized controlled trials worldwide, reporting 5,179 patients with PV, suggested that some certain CM interventions or combining CM with conventional medicine had promising results for PV 10.

Adopted Guidelines Of Care For The Topical Management Of Psoriasis From American And German Guidelines

Calcipotriol and Betamethasone Dipropionate for the Treatment of Psoriasis: A 52-Week Study. Calcipotriene is one of the most widely prescribed treatments for psoriasis in many countries, and its efficacy in mild to moderate psoriasis has already been shown in a meta-analysis of 37 clinical trials. The authors aimed to assess the effects and safety profile of calcipotriol/betamethasone dipropionate for the treatment of psoriasis vulgaris, using evidence based approach. In the pivotal Phase 3 clinical trial, over half of patients treated with Enstilar were Clear or Almost Clear by Week 4 as assessed by the Investigator Global Assessment (IGA) score of disease severity. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence.